| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.0259 | 45 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.3018 | 46 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.544 | 39 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.5452 | 39 |
| GSM780720 | Untreated after 4 days (C2_2) | 57.2246 | 62 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.6887 | 47 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.2256 | 38 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 53.8756 | 58 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.2116 | 38 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.0094 | 49 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.084 | 45 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.6659 | 40 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.2011 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.6984 | 47 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.2724 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.0159 | 45 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.373 | 29 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.0595 | 27 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 52.1814 | 54 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.611 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 51.9702 | 54 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.1791 | 46 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.6624 | 55 |